Wednesday, July 4, 2012

Winners Of The Romanian 2012 Quit&Win Contest Have Been Announced


Milford Ma, July 4, 2012-The Romanian 2012 Quit&Win Contest has concluded and winners are announced after being verified using NicCheck I test strips.
The Romanian 2012 Quit&Win Contest has concluded. This year the contest enrolled 273 participants and from these George Ghiorghisor of Calarasi and Mirela Barbu of Gaesti were identified as the 2 Grand Prize winners.
Participants went through a telephone screening process and then successful participants were validated through biomarker testing with NicCheck by entities such as Calarasi Public Health Authority and Gaesti Artic Plant Dispensary. The results were used to prove the winners were negative, non-smokers. The 2 Grand Prize winners will each receive a 2 persons (husband/wife), 11 day sojourn at the renown Life-Style Centers in Herghelia/Mures and Podis/Bacau respectively, valued at about $1000 each.

In addition, 4 people will be granted one year long subscriptions to British Medical Journal - Romanian Edition and Viata Medical (Medical Life) while the Publishing House Viata si Sanatate (Life & Health) will offer prizes in books and subscriptions to the Viata&Sanatate Magazine to the most active supporters.
The Romanian Quit&Win campaigns have persuaded thousands of people to quit smoking and NicCheck has been used since 2000 as the biomarker test to determine the ultimate winners.

NicCheck is a dry chemistry dipstick for the semi-quantitative measurement of nicotine and nicotine metabolites in urine as an aid in the verification of a person’s true smoking status. This 15 minute test yields a semi-quantitative measurement of a person’s nicotine consumption based on the color intensity of the reaction found on the NicCheck test strips.

Tuesday, April 24, 2012

Smoking Cessation Campaigns Around the World Using NicCheck to Confirm Success Once Again


Milford, Massachusetts; 4/24/2012 - Mossman Associates Inc. is pleased to announce that our NicCheck is being used once again within a number of Smoking Cessation Campaigns around the world.
Campaigns include: The John Tung Foundation in Taiwan, The Quit and Win Contest in Romania and The Quit to Win Challenge in Montreal, Canada. This represents consecutive years that we have been involved with these organizations and been a part of these well established campaigns.

Donald Mossman, President of Mossman Associates Inc. notes, "We are pleased to once again contribute to these programs which are designed to help those people trying to quit smoking. Our NicCheck product has been shown to be effective when used to monitor a person’s nicotine consumption as they reduce their nicotine dependence. 

Our test is simple and because it is a rapid visual test, it is conducive to being run in the field, lending itself nicely to smoking cessation programs as well as spot checks and remote health locations”.

For more information contact:

Donald Mossman, President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
508-488-6169 (P)
don@mossmanassociates.com

Thursday, October 6, 2011

CLIAWAIVED.com signs distribution deal with Mossman Associates, and licenses global co-marketing rights to Mossman’s rapid nicotine testing technology

CLIAWAIVED.com announced the execution of an agreement for the exclusive US distribution and global co-marketing rights to Mossman’s NicCheck, rapid nicotine testing technology.


San Diego, CA, October 1, 2011

CLIAWAIVED.COM, Inc., the leading internet based, multi-line distributor of POC (point-of- care) CLIA waived Diagnostic tests in the US and Mossman Associates Inc., a leading diagnostic test manufacturer, today announced the execution of an agreement for the exclusive US distribution rights along with global co-marketing rights to Mossman’s NicCheck products and rapid nicotine testing technology.

CLIAwaived.com has agreed to pay Mossman Associates, Inc. an undisclosed fee for exclusive US license rights of NicCheck branded products along with the right to sell Mossman’s rapid nicotine testing products globally under CLIAwaived’s private label brand. Mossman’s NicCheck products are an ideal fit for the CLIAwaived.com portfolio of diagnostic products and will be marketed both in the US and globally with dozens of other rapid diagnostics. Specifically, this addition is strategically aimed at serving the growth-oriented point-of-care diagnostic markets including the increasingly growing need for waived tests in the physician office lab, addiction treatment and clinical research markets. At present, NicCheck is the only FDA Cleared and CLIA waived semi-quantitative instant nicotine test on the market that is CLIA compliant for these market segments.

Donald Mossman, President of Mossman Associates, Inc. said “we are pleased that CLIAWAIVED.COM has opted to become our exclusive distributor in the USA. Their position as the premier site for ordering CLIA waived test kits is a natural fit for our NicCheck product. Their site will offer our existing customers an internet option not currently available to them while exposing our product to a much larger customer base.”

Tim Drapeau, President of CLIAwaived, Inc. said, " I am delighted that Mossman Associates has chosen CLIAwaived.com to sell, distribute and market their NicCheck rapid nicotine testing products exclusively in the US POC market. As a company specializing in distributing CLIA compliant devices we believe the NicCheck product line will dominate our target markets and strengthen our position and portfolio of CLIA waived rapid diagnostics.”

About CLIAWAIVED.COM

CLIAWAIVED.COM, is a leading, Internet based, multi-line distributor of CLIA Waived, point-of-care diagnostic products to the healthcare industry. CLIAWAIVED’s portfolio of distributed products includes rapid diagnostics for early diagnosis and treatment of various diseases and conditions.

About Mossman Associates, Inc.

Mossman Associates, Inc. is a manufacturer and distributor of medical diagnostic test kits whose portfolio of products includes rapid onsite products for detection and screening of drugs of abuse, nicotine and alcohol as well as a serological test for tuberculosis.
Contact: CLIAWAIVED.COM
Mr. Tim Drapeau, President
CLIAwaived,Inc.
11578 Sorrento Valley Road
San Diego, CA 92121
www.cliawaived.com

OR

Mossman Associates, Inc.
Mr. Donald Mossman
9 Village Circle
Milford, MA 01757
www.mossmanassociates.com
508-488-6169

Friday, April 1, 2011

NicCheck to be used within evidence based smoking cessation contests, results in time for World No Tobacco Day 2011

May 31, 2011 has been set aside as World No Tobacco Day. The 31st of May each year the World Health Organization (WHO) celebrates World No Tobacco Day, highlighting the health risks associated with tobacco. The WHO uses this day to be an advocate for effective policies to reduce tobacco consumption, specifically through tobacco control messages, and to promote adherence to the WHO Framework Convention on Tobacco Control.

The WHO Framework Convention on Tobacco Control is the world’s foremost tobacco control treaty. This treaty, negotiated under the auspices of the WHO, was put in place in 2005 and to date is the most widely embraced treaty in the history of the United Nations. Currently there are 172 parties endorsing this evidence-based treaty that reaffirms the rights of all people to the highest standard of health and provides new legal dimensions for cooperation in tobacco control.

Once again, Mossman Associates’ NicCheck test has been chosen to be the evidence based test used to confirm smoking cessation in a number of Quit and Win contests around the world. Completion of these and the announcements of the contest winners should be in time to celebrate World No Tobacco Day.

“We can think of no better way to celebrate the upcoming event than to continue our support of these types of contests”, quotes Donald Mossman, President of Mossman Associates. He continues, “Competitions in Finland, Canada, and Taiwan should all conclude in time to celebrate this noteworthy day. We look forward to working with other countries, universities and organizations that take on these types of programs”.

About Mossman Associates, Inc.

Mossman Associates, Inc is a privately held medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry. Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.

Wednesday, November 17, 2010

Mossman Associates Inc Announces It Is ISO 9001 Compliant.

November 17, 2010; Milford, MA. Mossman Associates Inc is proud to announce it is ISO 9001 compliant.

Mossman Associates Inc is proud to announce it is ISO 9001 compliant.

The compliance with ISO 9001 recognizes that the policies, practices and procedures of our company ensure consistent quality in the product and services we provide our clients. Compliance assures our clients can be confident that Mossman Associates Inc is dedicated to maintaining the highest efficiency and responsiveness in achieving our ultimate goal – guaranteed client satisfaction.

To maintain our compliance, Mossman Associates Inc will perform audits to ensure compliance and to assess initiatives for continued improvement. Our clients can be confident that we will continue to provide the high quality products and services they have come to expect well into the future. We believe that our decision is a proactive one that not only anticipates the demands of our clients, but also demonstrates our commitment to providing quality services to all our clients.

For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com

Wednesday, August 4, 2010

Website For Mossman Associates Inc Expanding

The website for Mossman Associates Inc is expanding and is due to be released at the end of this month. New features will include expanded choices for nicotine diagnostics, drugs of abuse, alcohol and the addition of HIV 1&2 tests.

NicCheck (the CLIA Waived test for nicotine) and MycoDot (serological test for TB) the original products in the diagnostic test kit line are still available and will be complimented by these new additions.

An improved Contact page, Calendar page and Blog page as well as movies and downloadable articles round out the extensive improvements made to the site.

Tuesday, June 15, 2010

Romanian Quit &Win 2010 Challenge Concludes Smoking Cessation Screening Using NicCheck I Test Strips



The Romanian Quit&Win 2010 Challenge, a yearly smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation.

Tuesday June 15, 2010 Mossman Associates, Inc., announced today that the Romanian Quit & Win 2010 Smoking Cessation Challenge, a yearly smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation among the potential contest winners.

Prof. Radu M. Negoescu, PhD, MPH, Head, Unit of Healthy Lifestyle Promotion of
The Institute of Public Health, has reported “Please accept our renewed thanks for giving us the possibility to validate Quit & Win 2010 Romania winners using NicCheck tests.
As usual, NicCheck did work well and helped a lot to distinguish among false and sincere competitors.

The campaign mobilized 245 participants competing for several 11 day sojourns in renown or just-opened Health (life style) Centers at Herghelia, county of Mures, and Podis, county of Bacau; such a sojourn is valued about $ 500. NicCheck testing has been applied to participants in drawing order after a successful telephonic interview of the witness and of the candidate. Testing was applied by qualified personnel from Public Health Authorities closest to candidate's residence.”

Donald Mossman, President of Mossman Associates is quoted as saying, "We are again pleased to be chosen to be involved with this important project. We have seen how our test can be used in the field, such as our involvement in the rural countryside of the Philippines, as well as by lab clinicians such as with the Canadian Quit and Win Challenge. Currently we are becoming more involved with doctors and how NicCheck can be used to better determine the amount of Nicotine Replacement Therapy (NRT) that is required for their patients. We feel strongly that the addition of NicCheck as a tool, for one’s smoking cessation efforts will improve results and help with kicking the habit ".
Donald Mossman, President
Mossman Associates, Inc.
9 Village Circle, Milford, MA 01757
508-488-6169 508-488-6169 (P)
508-418-1397 (F)
contact@mossmanassociates.com